BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 231 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $729,000 | +4.9% | 5,000 | -14.7% | 0.25% | +30.3% |
| Q1 2022 | $695,000 | -10.9% | 5,860 | +3.5% | 0.20% | -7.6% |
| Q4 2021 | $780,000 | +24.8% | 5,660 | +25.8% | 0.21% | +17.2% |
| Q3 2021 | $625,000 | +43.0% | 4,500 | 0.0% | 0.18% | +40.6% |
| Q2 2021 | $437,000 | +41.9% | 4,500 | 0.0% | 0.13% | +30.6% |
| Q1 2021 | $308,000 | -26.1% | 4,500 | -7.6% | 0.10% | -30.5% |
| Q4 2020 | $417,000 | +42.3% | 4,870 | +8.2% | 0.14% | +17.5% |
| Q3 2020 | $293,000 | +48.7% | 4,500 | +66.7% | 0.12% | -7.0% |
| Q2 2020 | $197,000 | +20.9% | 2,700 | -10.0% | 0.13% | +53.6% |
| Q4 2019 | $163,000 | +96.4% | 3,000 | +50.0% | 0.08% | +82.6% |
| Q3 2019 | $83,000 | – | 2,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $154,344,000 | 72.03% |
| Knoll Capital Management, LLC | 856,844 | $119,024,000 | 59.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,124,055 | $295,053,000 | 36.73% |
| ARS Investment Partners, LLC | 466,668 | $64,825,000 | 6.49% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 365,373 | $50,754,000 | 6.18% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $24,490,000 | 5.91% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 61,897 | $8,598,000 | 4.86% |
| DAFNA Capital Management LLC | 88,100 | $12,238,000 | 3.25% |
| Avidity Partners Management LP | 934,200 | $129,770,000 | 2.88% |
| Eventide Asset Management | 1,325,000 | $184,056,000 | 2.43% |